Hemme J Hijma (Hemme Hijma)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Pulmonary Artery

Neuropathic Pain

Top Venues

Clinical and translational science

Pain medicine (Malden, Mass.)

European journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yvonne Boyle, Hemme J Hijma, Jamie Rees, Jagtar Nijjar, Eirini Panoilia, Yolanda Alvarez, Sarah Siederer, Emma Greening, Edward C Emery, Kathy Abbott Banner, Geert Jan Groeneveld
Randomized, placebo-controlled study on the effects of intravenous GSK3858279 (anti-CCL17) on a battery of evoked pain tests in healthy participants. Clinical and translational science 17 (9) (2024)
Marella C E van Ruissen, Sebastiaan J W van Kraaij, Pim Gal, Wouter A Bakker, Hemme J Hijma, Geert Jan Groeneveld, Marieke L de Kam, Jacobus Burggraaf, Matthijs Moerland
Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat Stress. Journal of experimental pharmacology 16 (2024)
Hemme J Hijma, Ingrid Koopmans, Erica Klaassen, Robert Jan Doll, Rob G J A Zuiker, Geert Jan Groeneveld
A crossover study evaluating the sex-dependent and sensitizing effects of sleep deprivation using a nociceptive test battery in healthy subjects. British journal of clinical pharmacology (2022)
Johannes Heck, Ann-Kathrin Rath, Katrin Wons, Carsten Schumacher, Anna Kutschenko, Nina Noltemeyer, Sarana Ulaganathan, Luca J Voßiek, Hemme J Hijma, Jeroen van Smeden, Christoph Schröder, Dirk O Stichtenoth, Jacobus J Bosch, Christoph Schindler, Jacobus J Bosch
Students' guide to documentation in clinical trials. European journal of clinical pharmacology 78 (11) (2022)
Hemme J Hijma, Emilie M J van Brummelen, Pieter S Siebenga, Geert Jan Groeneveld
A phase I, randomized, double-blind, placebo-controlled, single- and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX-128, a highly selective Na v 1.8 inhibitor, in healthy adults. Clinical and translational science 15 (4) (2021)
Hemme J Hijma, Pieter S Siebenga, Marieke L de Kam, Geert Jan Groeneveld
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults. Pain medicine (Malden, Mass.) 22 (8) (2021)